Stocks
GoodRx Holdings (GDRX) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 172.6% | 365.3% | 259.2% | 259.2% | 243.6% | 141.2% | |||
| Changes by years, y/y, % | -337pp | +193pp | -106pp | 0pp | -16pp | -28.1% | |||
GoodRx Holdings. R&D/CAPEX, %
GoodRx Holdings. R&D/CAPEX, changes, pp
GoodRx Holdings (GDRX) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| R&D/CAPEX, % | 290.3% | 245.0% | 150.5% | 179.1% | 82.0% | 141.2% | ||
| Changes by years, y/y, % | +29pp | +4pp | -80pp | -30pp | -208pp | |||
| Changes by quarters, q/q, % | +81pp | -45pp | -95pp | +29pp | -97pp | |||
